Sponsor Dossier
Waymade
Sponsor Dossier for Waymade. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-LEVOTHYROXINE
- Brand: ARX-TRANEXAMIC
- Brand: MARAVIROC WAYMADE
- Brand: NEUPEDIX
- Brand: RISEDRONATE
- Brand: SEVELAMER
- Brand: THYROX
- Brand: TRANEXAMIC
About
Waymade is an Australian Private Company with ABN 85 635 010 598, registered in NSW. The company is active and GST-registered.
Portfolio
Waymade has six brands on the ARTG, all of which are indexable. All six brands have Product Information on file. One brand is PBS-listed, one has PBAC outcome(s) on record, and one has AusPAR(s) on record. Notable brands include Maraviroc Waymade, Neupedix, Risedronate, Thyrox, Tranexamic, and Trientine.
Therapeutic focus
— Rare Disease: 1 brand — Haematology: 1 brand — Endocrinology: 1 brand — Infectious Disease: 1 brand — Oncology: 1 brand — Cardiology: 1 brand
PBS footprint
One brand in Waymade's portfolio is PBS-listed, with the latest PBS schedule date touched on 1 May 2026.
Regulatory activity
The latest PBAC outcome for Waymade was recorded on 1 July 2024, with one brand holding PBAC outcome(s) on record. The latest AusPAR was issued on 7 January 2021, with one brand holding AusPAR(s) on record.